Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ApoScreen® Annexin V Apoptosis Kit-FITC

FACS, ICC
N° du produit ABIN376221
497,84 €
Plus frais de livraison 40,00 € et TVA
100 tests
Destination: France
Envoi sous 7 à 10 jours ouvrables

Aperçu rapide pour ApoScreen® Annexin V Apoptosis Kit-FITC (ABIN376221)

Antigène

Voir toutes Annexin V (ANXA5) Kits
Annexin V (ANXA5) (Annexin A5 (ANXA5))

Application

Flow Cytometry (FACS), Immunocytochemistry (ICC)
  • Conjugué

    FITC

    Fonction

    ApoScreen® Annexin V Apoptosis Kit-FITC

    Attributs du produit

    FITC ApoScreen® Annexin V Apoptosis Kit for use in flow cytometry and immunocytochemistry assays.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    E.coli expressed Annexin V

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Annexin V-FITC - Annexin V Binding Buffer PI - Annexin V Binding Buffer Annexin V Binding Buffer - Contains 0.1 % sodium azide and proprietary ingredients

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Protect conjugated products from light.
    Each reagent is stable for the period shown on the bottle label if stored as directed.

    Stock

    4 °C

    Stockage commentaire

    2-8°C
  • Rosso, Polotskaia, Bargonetti: "Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death." dans: Oncotarget, Vol. 6, Issue 33, pp. 34573-91, (2016) (PubMed).

    Polotskaia, Hoffman, Krett, Shanmugam, Rosen, Bargonetti: "8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers." dans: Molecular cancer therapeutics, Vol. 11, Issue 11, pp. 2495-504, (2012) (PubMed).

    Yan, Tan, Geng, Ju, Gao, Zhu: "Inhibition effect of siRNA-downregulated UHRF1 on breast cancer growth." dans: Cancer biotherapy & radiopharmaceuticals, Vol. 26, Issue 2, pp. 183-9, (2011) (PubMed).

  • Antigène

    Annexin V (ANXA5) (Annexin A5 (ANXA5))

    Autre désignation

    Annexin V

    Sujet

    Optional[Description]: ApoScreen® Annexin V Apoptosis Kit-FITC
Vous êtes ici:
Chat with us!